在一组 770 名患者中,催乳素水平在预测高催乳素血症病因方面的作用。

IF 1.6 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM
Archives of Endocrinology Metabolism Pub Date : 2024-09-11 eCollection Date: 2024-01-01 DOI:10.20945/2359-4292-2023-0391
Lucio Vilar, Clarice Freitas Vilar, Ruy Lyra, Luciano Albuquerque, Ana Carolina Thé Garrido, Patrícia Sampaio Gadelha, Erik Trovão Diniz, Marcos Almeida, Lucia Helena Cordeiro, Erico Higino de Carvalho, Ana Teresa Bezerra de Melo, Karoline Matias Medeiros, Gabriel Rodrigues de Assis Ferreira, José Coelho Mororó, Daniela Zago Ximenes, Camila Ribeiro Coutinho Madruga, Rosália de Oliveira Nunes, Yanna Queiroz Pereira de Sá, Luciana Ansaneli Naves
{"title":"在一组 770 名患者中,催乳素水平在预测高催乳素血症病因方面的作用。","authors":"Lucio Vilar, Clarice Freitas Vilar, Ruy Lyra, Luciano Albuquerque, Ana Carolina Thé Garrido, Patrícia Sampaio Gadelha, Erik Trovão Diniz, Marcos Almeida, Lucia Helena Cordeiro, Erico Higino de Carvalho, Ana Teresa Bezerra de Melo, Karoline Matias Medeiros, Gabriel Rodrigues de Assis Ferreira, José Coelho Mororó, Daniela Zago Ximenes, Camila Ribeiro Coutinho Madruga, Rosália de Oliveira Nunes, Yanna Queiroz Pereira de Sá, Luciana Ansaneli Naves","doi":"10.20945/2359-4292-2023-0391","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Determining the etiology of hyperprolactinemia is fundamental for selecting the most appropriate treatment strategy. The aim of this study was to evaluate the usefulness and accuracy of prolactin levels in predicting the etiology of nonphysiological hyperprolactinemia.</p><p><strong>Subjects and methods: </strong>In this retrospective study, we reviewed medical records of patients with nonphysiological hyperprolactinemia seen at two neuroendocrine reference centers located in Recife, Brazil, from January 2000 to December 2019.</p><p><strong>Results: </strong>The study included 770 patients aged 12-73 years (65% female). The three most frequent etiologies of hyperprolactinemia were prolactinomas (n = 263; 34.2%), drug-induced hyperprolactinemia (n = 160; 20.8%), and macroprolactinemia (n = 120; 15.6%). The highest mean prolactin levels were observed in cases of prolactinomas and idiopathic hyperprolactinemia. Most patients with hyperprolactinemia due to other etiologies had prolactin levels < 100 ng/mL, but these levels were also found in 16.5% of patients with microproplactinomas and in 20% of those with idiopathic hyperprolactinemia. Likewise, prolactin levels largely overlapped among patients with microprolactinomas, macroprolactinemia, and drug-induced hyperprolactinemia. Notably, prolactin levels > 250 ng/mL enabled a clear distinction between the etiologies of macroprolactinoma and nonfunctioning pituitary adenoma. Moreover, prolactin levels > 500 ng/mL were highly suggestive of macroprolactinomas, although they were also found in very few patients (<2%) with microprolactinomas or drug-induced hyperprolactinemia.</p><p><strong>Conclusion: </strong>Despite considerable overlap in prolactin levels among the different etiologies of hyperprolactinemia, values > 250 ng/mL allowed a clear distinction between macroprolactinomas and nonfunctioning pituitary adenomas. Furthermore, prolactin levels > 500 ng/mL were almost exclusively found in patients with prolactinomas.</p>","PeriodicalId":54303,"journal":{"name":"Archives of Endocrinology Metabolism","volume":"68 ","pages":"e230391"},"PeriodicalIF":1.6000,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460971/pdf/","citationCount":"0","resultStr":"{\"title\":\"Usefulness of prolactin levels in predicting the etiology of hyperprolactinemia in a cohort of 770 patients.\",\"authors\":\"Lucio Vilar, Clarice Freitas Vilar, Ruy Lyra, Luciano Albuquerque, Ana Carolina Thé Garrido, Patrícia Sampaio Gadelha, Erik Trovão Diniz, Marcos Almeida, Lucia Helena Cordeiro, Erico Higino de Carvalho, Ana Teresa Bezerra de Melo, Karoline Matias Medeiros, Gabriel Rodrigues de Assis Ferreira, José Coelho Mororó, Daniela Zago Ximenes, Camila Ribeiro Coutinho Madruga, Rosália de Oliveira Nunes, Yanna Queiroz Pereira de Sá, Luciana Ansaneli Naves\",\"doi\":\"10.20945/2359-4292-2023-0391\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Determining the etiology of hyperprolactinemia is fundamental for selecting the most appropriate treatment strategy. The aim of this study was to evaluate the usefulness and accuracy of prolactin levels in predicting the etiology of nonphysiological hyperprolactinemia.</p><p><strong>Subjects and methods: </strong>In this retrospective study, we reviewed medical records of patients with nonphysiological hyperprolactinemia seen at two neuroendocrine reference centers located in Recife, Brazil, from January 2000 to December 2019.</p><p><strong>Results: </strong>The study included 770 patients aged 12-73 years (65% female). The three most frequent etiologies of hyperprolactinemia were prolactinomas (n = 263; 34.2%), drug-induced hyperprolactinemia (n = 160; 20.8%), and macroprolactinemia (n = 120; 15.6%). The highest mean prolactin levels were observed in cases of prolactinomas and idiopathic hyperprolactinemia. Most patients with hyperprolactinemia due to other etiologies had prolactin levels < 100 ng/mL, but these levels were also found in 16.5% of patients with microproplactinomas and in 20% of those with idiopathic hyperprolactinemia. Likewise, prolactin levels largely overlapped among patients with microprolactinomas, macroprolactinemia, and drug-induced hyperprolactinemia. Notably, prolactin levels > 250 ng/mL enabled a clear distinction between the etiologies of macroprolactinoma and nonfunctioning pituitary adenoma. Moreover, prolactin levels > 500 ng/mL were highly suggestive of macroprolactinomas, although they were also found in very few patients (<2%) with microprolactinomas or drug-induced hyperprolactinemia.</p><p><strong>Conclusion: </strong>Despite considerable overlap in prolactin levels among the different etiologies of hyperprolactinemia, values > 250 ng/mL allowed a clear distinction between macroprolactinomas and nonfunctioning pituitary adenomas. Furthermore, prolactin levels > 500 ng/mL were almost exclusively found in patients with prolactinomas.</p>\",\"PeriodicalId\":54303,\"journal\":{\"name\":\"Archives of Endocrinology Metabolism\",\"volume\":\"68 \",\"pages\":\"e230391\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11460971/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Endocrinology Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.20945/2359-4292-2023-0391\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Endocrinology Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20945/2359-4292-2023-0391","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:确定高泌乳素血症的病因是选择最合适的治疗策略的基础。本研究旨在评估催乳素水平在预测非生理性高泌乳素血症病因方面的实用性和准确性:在这项回顾性研究中,我们回顾了2000年1月至2019年12月在巴西累西腓的两家神经内分泌参考中心就诊的非生理性高泌乳素血症患者的病历:研究共纳入 770 名年龄在 12-73 岁之间的患者(65% 为女性)。高泌乳素血症最常见的三种病因是泌乳素瘤(263人;34.2%)、药物诱发的高泌乳素血症(160人;20.8%)和巨泌乳素血症(120人;15.6%)。催乳素瘤和特发性高催乳素血症患者的催乳素平均水平最高。大多数因其他病因导致的高泌乳素血症患者的泌乳素水平低于100纳克/毫升,但16.5%的微泌乳素瘤患者和20%的特发性高泌乳素血症患者的泌乳素水平也低于100纳克/毫升。同样,微泌乳素瘤患者、巨泌乳素血症患者和药物诱发的高泌乳素血症患者的泌乳素水平也有很大程度的重叠。值得注意的是,泌乳素水平大于 250 纳克/毫升可明确区分巨泌乳素瘤和无功能垂体腺瘤的病因。此外,泌乳素水平> 500 ng/mL也高度提示为巨泌乳素瘤,尽管在极少数患者中也发现了这种情况(结论:尽管不同病因导致的高泌乳素血症在泌乳素水平上有相当大的重叠,但泌乳素水平> 250 ng/mL可明确区分大泌乳素瘤和无功能垂体腺瘤。此外,催乳素水平大于 500 纳克/毫升的患者几乎都是催乳素瘤患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Usefulness of prolactin levels in predicting the etiology of hyperprolactinemia in a cohort of 770 patients.

Objective: Determining the etiology of hyperprolactinemia is fundamental for selecting the most appropriate treatment strategy. The aim of this study was to evaluate the usefulness and accuracy of prolactin levels in predicting the etiology of nonphysiological hyperprolactinemia.

Subjects and methods: In this retrospective study, we reviewed medical records of patients with nonphysiological hyperprolactinemia seen at two neuroendocrine reference centers located in Recife, Brazil, from January 2000 to December 2019.

Results: The study included 770 patients aged 12-73 years (65% female). The three most frequent etiologies of hyperprolactinemia were prolactinomas (n = 263; 34.2%), drug-induced hyperprolactinemia (n = 160; 20.8%), and macroprolactinemia (n = 120; 15.6%). The highest mean prolactin levels were observed in cases of prolactinomas and idiopathic hyperprolactinemia. Most patients with hyperprolactinemia due to other etiologies had prolactin levels < 100 ng/mL, but these levels were also found in 16.5% of patients with microproplactinomas and in 20% of those with idiopathic hyperprolactinemia. Likewise, prolactin levels largely overlapped among patients with microprolactinomas, macroprolactinemia, and drug-induced hyperprolactinemia. Notably, prolactin levels > 250 ng/mL enabled a clear distinction between the etiologies of macroprolactinoma and nonfunctioning pituitary adenoma. Moreover, prolactin levels > 500 ng/mL were highly suggestive of macroprolactinomas, although they were also found in very few patients (<2%) with microprolactinomas or drug-induced hyperprolactinemia.

Conclusion: Despite considerable overlap in prolactin levels among the different etiologies of hyperprolactinemia, values > 250 ng/mL allowed a clear distinction between macroprolactinomas and nonfunctioning pituitary adenomas. Furthermore, prolactin levels > 500 ng/mL were almost exclusively found in patients with prolactinomas.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Archives of Endocrinology Metabolism
Archives of Endocrinology Metabolism Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.90
自引率
5.90%
发文量
107
审稿时长
7 weeks
期刊介绍: The Archives of Endocrinology and Metabolism - AE&M – is the official journal of the Brazilian Society of Endocrinology and Metabolism - SBEM, which is affiliated with the Brazilian Medical Association. Edited since 1951, the AE&M aims at publishing articles on scientific themes in the basic translational and clinical area of Endocrinology and Metabolism. The printed version AE&M is published in 6 issues/year. The full electronic issue is open access in the SciELO - Scientific Electronic Library Online e at the AE&M site: www.aem-sbem.com. From volume 59 on, the name was changed to Archives of Endocrinology and Metabolism, and it became mandatory for manuscripts to be submitted in English for the online issue. However, for the printed issue it is still optional for the articles to be sent in English or Portuguese. The journal is published six times a year, with one issue every two months.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信